Shopping Cart
- Remove All
- Your shopping cart is currently empty
Zymosan A, a polysaccharide derived from Saccharomyces cerevisiae, is a TLR2 agonist that can upregulate ASCL2 through the TLR2 and Wnt signaling pathways, promoting the regeneration of intestinal stem cells (ISCs) after radiation-induced injury. It exhibits significant radioprotective effects, helping to prevent and alleviate IR-induced intestinal damage. Additionally, Zymosan A can induce immune responses, inflammation, anorexia, and elevated body temperature, and is commonly used to establish peritonitis models.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | $35 | In Stock | |
100 mg | $52 | In Stock |
Description | Zymosan A, a polysaccharide derived from Saccharomyces cerevisiae, is a TLR2 agonist that can upregulate ASCL2 through the TLR2 and Wnt signaling pathways, promoting the regeneration of intestinal stem cells (ISCs) after radiation-induced injury. It exhibits significant radioprotective effects, helping to prevent and alleviate IR-induced intestinal damage. Additionally, Zymosan A can induce immune responses, inflammation, anorexia, and elevated body temperature, and is commonly used to establish peritonitis models. |
In vivo | Methods: Zymosan A (25.0 mg/Kg, intraperitoneal injection, 24 and 2 hours before IR) was given to mice to observe its effect on IR-induced intestinal damage in mice. Results: The radioprotective effect of Zymosan A was even better when it was given 24 and 2 hours before IR. Zymosan A had a significant radioprotective effect on irradiated mice, and Zymosan A alleviated IR-induced intestinal damage in mice. [1] |
Synonyms | Zymosan A from Saccharomyces cerevisia |
Cas No. | 58856-93-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Solubility Information | H2O: < 1 mg/mL (insoluble) DMSO: 1 mg/mL, when pH is adjusted to 4 with HCl. Sonication is recommmended. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.